Effects of tanshinone IIA on the hepatotoxicity and gene expression involved in alcoholic liver disease

被引:28
|
作者
Yin, Hu-Quan [1 ,2 ]
Kim, Youn-Su [1 ,2 ]
Choi, You-Jin [1 ,2 ]
Kim, Youn-Chul [3 ]
Sohn, Dong-Hwan [3 ]
Ryu, Shi-Yong [4 ]
Lee, Byung-Hoon [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
[2] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul 151742, South Korea
[3] Wonkwang Univ, Coll Pharm, Iksan 570749, Jeonbuk, South Korea
[4] Korea Res Inst Chem Technol, Taejon 305343, South Korea
基金
新加坡国家研究基金会;
关键词
Salvia miltiorrhiza; tanshinone IIA; alcoholic liver disease; oxidative stress; lipid metabolism;
D O I
10.1007/s12272-001-1209-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tanshinone IIA is one of the most abundant constituents of the root of Salvia miltiorrhiza BUNGE which exerts antioxidant and anti-inflammatory actions in many experimental disease models. In the present study, we demonstrated that the standardized fraction of S. miltiorrhiza (Sm-SF) was able to protect RAW 264.7 cells from ethanol-and lipopolysaccharide (LPS)-induced production of superoxide radical, activation of NADPH oxidase and subsequently death of the cells. Among four main components of Sm-SF, tanshinone IIA was the most potent in protecting cells from LPS-and ethanol-induced cytotoxicity. LPS or ethanol induced the expression of CD14, iNOS, and SCD1 and decreased RXR-alpha, which was completely reversed by tanshinone IIA. In H4IIEC3 cells, 10 mu M tanshinone IIA effectively blocked ethanol-induced fat accumulation as evidenced by Nile Red binding assay. These results indicate that tanshinone IIA may have potential to inhibit alcoholic liver disease by reducing LPS-and ethanol-induced Kupffer cell sensitization, inhibiting synthesis of reactive oxygen/nitrogen species, inhibiting fatty acid synthesis and stimulating fatty acid oxidation.
引用
收藏
页码:659 / 665
页数:7
相关论文
共 50 条
  • [41] The Interleukin-17 Pathway Is Involved in Human Alcoholic Liver Disease
    Lemmers, Arnaud
    Moreno, Christophe
    Gustot, Thierry
    Marechal, Raphael
    Degre, Delphine
    Demetter, Pieter
    de Nadai, Patricia
    Geerts, Albert
    Quertinmont, Eric
    Vercruysse, Vincent
    Le Moine, Olivier
    Deviere, Jacques
    HEPATOLOGY, 2009, 49 (02) : 646 - 657
  • [42] Gene Expression Profiling in Liver Transplant Recipients With Alcoholic Cirrhosis
    Hassan-Montero, L.
    Bueno, P.
    Olmedo, C.
    Comino, A. M.
    Muffak-Granero, K.
    Garcia-Alcalde, F.
    Serradilla, M.
    Villar, J. M.
    Garrote, D.
    Blanco, A.
    Ferron, J. A.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) : 2955 - 2958
  • [43] Expression QTL analysis of a gene expression signature which predicts advanced non-alcoholic fatty liver disease
    Garrett, Melanie E.
    Moylan, Cynthia A.
    Gibson, Jason
    Yang, Hyuna
    Pang, Herbert
    Dellinger, Andrew
    Suzuki, Ayako
    Tillmann, Hans L.
    Guy, Cynthia D.
    Abdelmalek, Manal F.
    Murphy, Susan K.
    Diehl, Anna Mae
    Hauser, Michael
    Ashley-Koch, Allison E.
    HEPATOLOGY, 2012, 56 : 267A - 268A
  • [44] Gene expression signature of exercise and change of diet on non-alcoholic fatty liver disease in mice
    Melo, L.
    Hagar, A.
    Klaunig, J. E.
    COMPARATIVE EXERCISE PHYSIOLOGY, 2022, 18 (02) : 143 - 154
  • [45] EXPRESSION OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GENE IS DECREASED IN EXPERIMENTAL ALCOHOLIC LIVER-DISEASE
    WAN, YJY
    MORIMOTO, M
    THURMAN, RG
    BOJES, HK
    FRENCH, SW
    LIFE SCIENCES, 1994, 56 (05) : 307 - 317
  • [46] Comparison of hepatic and peripheral blood lymphocyte gene expression in non-alcoholic fatty liver disease
    Gawrieh, Samer
    Drigalenko, Eugene
    Littrell, Jack
    Komorowski, Richard
    Wallace, James R.
    Goldblatt, Matthew I.
    Goring, Harald H.
    Olivier, Michael
    HEPATOLOGY, 2013, 58 : 556A - 556A
  • [47] CD24 Gene Expression as a Risk Factor for Non-Alcoholic Fatty Liver Disease
    Amin, Mona A. A.
    Ragab, Halla M. M.
    Abd El Maksoud, Nabila
    Abd Elaziz, Wafaa
    DIAGNOSTICS, 2023, 13 (05)
  • [48] Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease
    Malaguarnera, L.
    Di Rosa, M.
    Zambito, A. M.
    dell'Ombra, N.
    Nicoletti, F.
    Malaguarnera, M.
    GUT, 2006, 55 (09) : 1313 - 1320
  • [49] Kombiglyze (metformin and saxagliptin)-induced hepatotoxicity in a patient with non-alcoholic fatty liver disease
    Thalha, Abdul Malik
    Mahadeva, Sanjiv
    Tan, Alexander Tong Boon
    Mun, Kein Seong
    JGH OPEN, 2018, 2 (05): : 242 - 245
  • [50] Role of mutations of HFE gene in non-alcoholic steatohepatitis and alcoholic liver disease
    Pucelikova, T
    Cieslarova, B
    Putova, I
    Hruba, I
    Stritesky, J
    Palicka, V
    Horak, J
    JOURNAL OF HEPATOLOGY, 2002, 36 : 151 - 151